TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35272399

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided electroacupuncture at suprahyoid muscle group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional acupuncture at Lianquan (CV 23), Wangu (GB 12) and Fengchi (GB 20)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional electroacupuncture at suprahyoid muscle group
Number of subjects: 120
Study: 33374033

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Blister fluid (control)
Number of subjects: 16
Study: 36371742

Group type: EXPERIMENTAL
Intervention: Ketorolac (non-opioid)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oxycodone-acetaminophen (opioid)
Number of subjects: 90
Study: 33421333

Group type: EXPERIMENTAL
Intervention: Expiratory muscle training (EMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group (lowest pressure 5 cmH2O)
Number of subjects: 30
Study: 32663820

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CTD) 12.5 mg once daily (QD)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 35652533

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 37
Study: 33665897

Group type: EXPERIMENTAL
Intervention: Willingness to participate in health/medical research
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Willingness to participate in randomized controlled trials of medications
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Subjective knowledge of research
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Perceived benefits of research
Number of subjects: 200
Study: 32799565

Group type: EXPERIMENTAL
Intervention: Generic empagliflozin tablet (25 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Brand-named empagliflozin tablet (Jardiance®) (25 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: High-fat food effect
Number of subjects: 48
Study: 34537091

Group type: EXPERIMENTAL
Intervention: Early surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initial conservative treatment
Number of subjects: 0
Study: 35773718

Group type: EXPERIMENTAL
Intervention: Mobile device-based cognitive behavior therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pharmacological treatments (Control group)
Number of subjects: 0
Study: 34232202

Group type: EXPERIMENTAL
Intervention: Magnetic field therapy (3 mT and 10 Hz) for 30 minutes daily for 11 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (no magnetic field therapy)
Number of subjects: 38
Study: 32955839

Group type: EXPERIMENTAL
Intervention: Pelvic and core strength training (PCST) program, 8 weeks, twice/week
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CG), normal training without additional pelvic and core strengthening
Number of subjects: 29
Study: 35657948

Group type: EXPERIMENTAL
Intervention: Intramuscular depot medroxyprogesterone acetate
Number of subjects: 5768

Group type: EXPERIMENTAL
Intervention: Copper intrauterine device
Number of subjects: 5768

Group type: EXPERIMENTAL
Intervention: Levonorgestrel implant
Number of subjects: 5768
Study: 34394913

Group type: EXPERIMENTAL
Intervention: Bufei Huoxue (BFHX) capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 0
Study: 32629035

Group type: EXPERIMENTAL
Intervention: Antiviral therapy (90.9% acyclovir, 6.2% ganciclovir, 2.9% both)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control (no antiviral therapy)
Number of subjects: 306
Study: 35431897

Group type: EXPERIMENTAL
Intervention: IERMS-based intervention for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 35190566

Group type: EXPERIMENTAL
Intervention: PPSF with pointed lotus-style regulator (Group C)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PPSF with flat end lotus-style regulator (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional PPSF (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 60
Study: 33259452

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygenation (HFNO)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard facemask (SFM)
Number of subjects: 34
Study: 35833805

Group type: EXPERIMENTAL
Intervention: Aflibercept monotherapy (2.0 mg intravitreous)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Bevacizumab first (1.25 mg intravitreous)
Number of subjects: 312
Study: 34528239

Group type: EXPERIMENTAL
Intervention: rhTPO 300 u/kg for 2 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: eltrombopag 25 mg/day for 2 weeks
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: rhTPO 300 u/kg
Number of subjects: 96

Group type: COMPARATOR
Intervention: eltrombopag 25 mg/day
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: rhTPO and eltrombopag
Number of subjects: 96
Study: 35738236

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model using whole axial brain T2-weighted MR images
Number of subjects: 1233
Study: 32962657

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 18
Study: 33921952

Group type: EXPERIMENTAL
Intervention: Back School Postural Education Program (GA) - three sessions of 45 min each, at intervals of 1 week.
Number of subjects: 153

Group type: COMPARATOR
Intervention: Back School Postural Education Program (GB) - one theoretical session of 90 min for all students.
Number of subjects: 153
Study: 33415861

Group type: EXPERIMENTAL
Intervention: Combined acupuncture-medicine anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous anesthesia
Number of subjects: 60
Study: 33342328

Group type: EXPERIMENTAL
Intervention: Structured pre-visit planning intervention
Number of subjects: 280

Group type: COMPARATOR
Intervention: Standard reminder call (Control)
Number of subjects: 280
Study: 34166299

Group type: EXPERIMENTAL
Intervention: Ayahuasca
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 35904293

Group type: EXPERIMENTAL
Intervention: Non-immunogenic staphylokinase (NS)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Alteplase (A)
Number of subjects: 336
Study: 33675794

Group type: EXPERIMENTAL
Intervention: COVID-19 infection
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Early COVID-19 infection (before 32 weeks gestation)
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Late COVID-19 infection (after 32 weeks gestation)
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Control group (women with negative SARS-CoV-2 test)
Number of subjects: 1856
Study: 33244202

Group type: EXPERIMENTAL
Intervention: High-risk group based on DNA methylation classification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-risk group based on DNA methylation classification
Number of subjects: 0
Study: 35954713

Group type: EXPERIMENTAL
Intervention: 1% CHX gel
Number of subjects: 38

Group type: COMPARATOR
Intervention: 0.12% CHX solution
Number of subjects: 38
Study: 34644228

Group type: EXPERIMENTAL
Intervention: NOMAC‐E2
Number of subjects: 101498

Group type: COMPARATOR
Intervention: COCLNG
Number of subjects: 101498
Study: 33150743

Group type: EXPERIMENTAL
Intervention: Obesogenic medications
Number of subjects: 5145
Study: 35855954

Group type: EXPERIMENTAL
Intervention: sGDNF in CHB patients with fibrosis (28.4 pg/ml)
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: sGDNF in CHB patients with cirrhosis (33.8 pg/ml)
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: sGDNF diagnostic accuracy
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: sGDNF-high group
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: sGDNF
Number of subjects: 735
Study: 34482050

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (n = 13 participants)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard-of-care (n = 14 participants)
Number of subjects: 32
Study: 36123929

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 0
Study: 33929807

Group type: EXPERIMENTAL
Intervention: Clareon IOL
Number of subjects: 40

Group type: COMPARATOR
Intervention: AcrySof IQ IOL
Number of subjects: 40
Study: 32851809

Group type: EXPERIMENTAL
Intervention: Venglustat l‐malate (2, 5, 15, 25, 50, 100, or 150 mg) single oral dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venglustat l‐malate (5, 10, or 20 mg) repeated once‐daily oral doses for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venglustat l‐malate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venglustat
Number of subjects: 0
Study: 32296197

Group type: EXPERIMENTAL
Intervention: Concomitant chemoradiotherapy with temozolamide after two cycles of standard chemotherapy (Group-B)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Radiotherapy alone (Group-A)
Number of subjects: 64
Study: 36424680

Group type: EXPERIMENTAL
Intervention: QFR-guided strategy (PCI performed only if QFR ≤0.80)
Number of subjects: 3825

Group type: COMPARATOR
Intervention: Angiography-guided strategy
Number of subjects: 3825

Group type: EXPERIMENTAL
Intervention: QFR-guided strategy
Number of subjects: 3825
Study: 34218071

Group type: EXPERIMENTAL
Intervention: Educational intervention based on virtual clinical simulation and problem‐based learning using the Diagnostician Nurse software
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional class on clinical reasoning skills (Control)
Number of subjects: 32
Study: 33861669

Group type: EXPERIMENTAL
Intervention: Ultra-modified internal sphincterotomy (UMIS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Closed lateral internal sphincterotomy (CLIS)
Number of subjects: 200
Study: 32608151

Group type: EXPERIMENTAL
Intervention: 755 nm picosecond Alexandrite laser treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 16
Study: 36178833

Group type: EXPERIMENTAL
Intervention: Cancer-frame version of the questionnaire
Number of subjects: 1803

Group type: EXPERIMENTAL
Intervention: Symptom-frame version of the questionnaire
Number of subjects: 1803

Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 1803

Group type: COMPARATOR
Intervention: Comparison of response rates based on wording
Number of subjects: 1803

Group type: COMPARATOR
Intervention: Regional GPs
Number of subjects: 1803
Study: 34032389

Group type: EXPERIMENTAL
Intervention: Comprehensive diabetes treatment (inpatient treatment for 2 weeks)
Number of subjects: 61
Study: 32822260

Group type: EXPERIMENTAL
Intervention: 45 minutes of fixed, moderate-intensity cycling followed by an incremental ride to exhaustion
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 45 minutes of fixed, moderate-intensity cycling
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham capsule
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Longer duration exercise (up to 45 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: HI/EE performed following a sustained bout of dehydrating activity
Number of subjects: 21
Study: 35598024

Group type: EXPERIMENTAL
Intervention: lecanemab, an anti-Aβ protofibril antibody
Number of subjects: 0
Study: 32139485

Group type: EXPERIMENTAL
Intervention: Tele-continuous EEG (tele-cEEG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tele-routine EEG (Tele-rEEG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tele-cEEG
Number of subjects: 0
Study: 33668304

Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation based on 200 m fast walking test (200 mFWT)
Number of subjects: 19
Study: 34490952

Group type: EXPERIMENTAL
Intervention: Predictive models for hip/femur fractures
Number of subjects: 270000

Group type: EXPERIMENTAL
Intervention: Predictive models for major osteoporotic fractures
Number of subjects: 270000
Study: 32636283

Group type: EXPERIMENTAL
Intervention: Occupational advice intervention
Number of subjects: 66
Study: 36271942

Group type: COMPARATOR
Intervention: ACE inhibitor (enalapril)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (CaCO3)
Number of subjects: 48
Study: 32978751

Group type: EXPERIMENTAL
Intervention: Exercise + Amino Acid Supplementation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Exercise + Placebo Supplementation
Number of subjects: 130
Study: 33514787

Group type: EXPERIMENTAL
Intervention: Fluoride-free hydroxyapatite toothpaste (used three times daily)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Fluoride toothpaste (control group)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Fluoride-free hydroxyapatite toothpaste
Number of subjects: 207
Study: 33261642

Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 36122608

Group type: EXPERIMENTAL
Intervention: IoT-assisted TIGER
Number of subjects: 18

Group type: COMPARATOR
Intervention: Task-specific motor training (TSMT)
Number of subjects: 18
Study: 34414946

Group type: EXPERIMENTAL
Intervention: Nursing intervention measures
Number of subjects: 136

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 136
Study: 35848716

Group type: EXPERIMENTAL
Intervention: Physical activity program based on intelligent wearable devices (N = 47)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Internet-based modified behavioral activation program (N = 48)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Treatment-as-usual (N = 48)
Number of subjects: 143
Study: 34226217

Group type: EXPERIMENTAL
Intervention: Subclinical LVD
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Abnormal LARS
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Subclinical AF
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: MoCA score consistent with MCI
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Non-adherence to AF screening
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Multivariable logistic regression
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Subclinical AF and cardiac dysfunction
Number of subjects: 337
Study: 34751632

Group type: EXPERIMENTAL
Intervention: Cognitive change strategies for Black patients
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Validation strategies for Black patients
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Time spent on cognitive change strategies
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Time spent on validation strategies
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Importance of validation strategies
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Positive racial attitudes among therapists
Number of subjects: 218
Study: 34118916

Group type: EXPERIMENTAL
Intervention: Housing First + supportive services (n=120)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Supportive services alone (n=120)
Number of subjects: 240
Study: 32393252

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg Q4W for 16 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33938832

Group type: EXPERIMENTAL
Intervention: Propofol + Normal saline (PS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol + Dexmedetomidine (PD)
Number of subjects: 40
Study: 32216762

Group type: EXPERIMENTAL
Intervention: gPM+ intervention
Number of subjects: 480

Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 480
Study: 35905657

Group type: EXPERIMENTAL
Intervention: MED diet plus whole fresh eggs (1 whole egg/1000 kcal; MED+E)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: MED diet without whole eggs (MED‐E)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control American diet (AAD)
Number of subjects: 39
Study: 32604422

Group type: EXPERIMENTAL
Intervention: Mobile force platform KMP (Motosana) measuring maximum force, power, and balance.
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Mobile force platform KMP (Motosana) measuring one leg standing without holding, transient help, or permanent holding at armrests.
Number of subjects: 63
Study: 32949779

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) at 1 mA for 15 minutes
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (tDCS)
Number of subjects: 3
Study: 36105381

Group type: EXPERIMENTAL
Intervention: BUZZY device with anesthetic gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cold alone with anesthetic gel
Number of subjects: 30
Study: 33200887

Group type: EXPERIMENTAL
Intervention: GSK3640254 (1-700 mg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GSK3640254
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: GSK3640254 mesylate salt
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 36114460

Group type: EXPERIMENTAL
Intervention: Opioid-containing anesthesia (OCA) with fentanyl
Number of subjects: 40

Group type: COMPARATOR
Intervention: Opioid-free anesthesia (OFA)
Number of subjects: 40
Study: 34039414

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32757065

Group type: EXPERIMENTAL
Intervention: Carbohydrate-protein solution (CHO-P; 0.8 g carbohydrate kg BM-1 + 0.8 g protein kg BM-1)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Carbohydrate (CHO; 1.6 g per kg body mass)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups (CHO and CHO-P)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Carbohydrate-protein solution (CHO-P)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 25
Study: 34260829

Group type: EXPERIMENTAL
Intervention: Intravitreal conbercept (IVC)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Sham IVC
Number of subjects: 157
Study: 34521655

Group type: EXPERIMENTAL
Intervention: No arterial catheter insertion until absolutely needed (less invasive intervention)
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Systematic arterial catheter insertion in the early hours of shock (usual care)
Number of subjects: 1010
Study: 34473389

Group type: EXPERIMENTAL
Intervention: Self-completed survey measuring skin cancer risk factors
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Self-completed survey measuring sun exposure
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Self-completed survey measuring treatment of skin cancers
Number of subjects: 238
Study: 32116211

Group type: EXPERIMENTAL
Intervention: Pharmacologic treatment
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 915

Group type: EXPERIMENTAL
Intervention: Combination of non-pharmacologic and pharmacologic therapies
Number of subjects: 915
Study: 35488182

Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (SRT)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Regional nodal/distant metastasis on PSMA-PET
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (SRT) with regional/distant metastasis on PSMA-PET
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (SRT) with EAU high-risk status
Number of subjects: 137

Group type: COMPARATOR
Intervention: EAU high-risk status
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Regional/distant metastasis on PSMA-PET in EAU high-risk group
Number of subjects: 137
Study: 34509775

Group type: EXPERIMENTAL
Intervention: Nightly medication use with standard-dose zolpidem (QHS)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intermittent dosing with standard-dose zolpidem and placebos (IDwP)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Continued QHS full dose treatment (FD/FD)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intermittent dosing with standard-dose zolpidem and placebos (FD/VD)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Intermittent dosing with placebos (VD/VD)
Number of subjects: 55
Study: 35924312

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (iCBT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 21
Study: 33122486

Group type: EXPERIMENTAL
Intervention: Pandemic period (TURKMI-2)
Number of subjects: 1113
Study: 34463952

Group type: EXPERIMENTAL
Intervention: ColourSpot app
Number of subjects: 772

Group type: COMPARATOR
Intervention: Ishihara Unlettered test
Number of subjects: 772

Group type: COMPARATOR
Intervention: Neitz Test
Number of subjects: 772
Study: 32108442

Group type: EXPERIMENTAL
Intervention: Sweet breakfast (30% by weight added sugar; average 32 g of sugar)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Plain breakfast (no added sugar; average 8 g of sugar)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sweet breakfast
Number of subjects: 29
Study: 35451977

Group type: EXPERIMENTAL
Intervention: High-intensity digital promotion in privileged urban localities
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Traditional high-intensity promotion in less privileged urban localities
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-intensity promotion in rural localities
Number of subjects: 27
Study: 34698782

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injections (n=48)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline) injections (n=52)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison of PRP vs Placebo
Number of subjects: 100
Study: 32006293

Group type: EXPERIMENTAL
Intervention: MISSION-CJ intervention
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study: 34225027

Group type: EXPERIMENTAL
Intervention: Monetary reinforcement for every correct response on a theory of mind (ToM) task
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-reward condition with no feedback
Number of subjects: 70
Study: 35559516

Group type: EXPERIMENTAL
Intervention: Prebiotic supplement
Number of subjects: 0